Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aggregated tau protein refers to the abnormal accumulation and clustering of tau proteins into insoluble aggregates within neurons, a pathological hallmark of Alzheimer's disease (AD) and other tauopathies. Hyperphosphorylation and truncation of tau are key drivers of aggregation, leading to disruption of microtubule function, impaired axonal transport, and neuronal degeneration. It is a therapeutic target.
Inhibition of tau aggregation; promotion of aggregate disassembly; prevention of hyperphosphorylation; enhancement of microtubule stability
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aggregated Tau Protein (Aggregated Tau).